At the European Culture of Cardiology Congress 2011 in Paris.

Research has demonstrated variability in following AF management guidelines, possibly placing the lives of thousands of AF patients at risk and resulting in an elevated burden on healthcare systems , stated Professor John Camm, Professor of Clinical Cardiology, St George’s University, London, UK – and co-author of the AFIP tool. The availability of new therapies will probably encourage the management of AF in main care, where early and opportunistic screening could prevent severe consequences of AF for patients ultimately. To address the global public health concern, the AF AWARE campaign convened a combined group of international experts to build up the AFIP tool, which helps bring PCP practice nearer to AF management guidelines.ATS Medical: First human robot assisted endoscopic aortic valve replacing in the Midwest ATS Medical, Inc. Balkhy, M.D., at the Wisconsin Heart Medical center in Milwaukee, Wisconsin. The ATS 3f Aortic Bioprosthesis is usually uniquely suited for use in minimally invasive procedures, in robot-assisted aortic valve alternative especially. Balkhy. With the intro of the ATS 3f Aortic Bioprosthesis to the U.S. Marketplace, surgeons have quickly identified its unique prospect of use in less invasive port access and robot assisted methods. Balkhy is just the next one of these procedures in the United States to become performed with robotic support, and is another important step toward offering surgeons and individuals better options for the treatment of structural heart disease lacking any open sternotomy.